|
Michael R. Sperling, M.D., is Baldwin Keyes
Professor of Neurology and Vice Chair for Research at the Sidney Kimmel Medical
College at Thomas Jefferson University, and Director of the Jefferson
Comprehensive Epilepsy Center. He is an internationally recognized
clinician-scientist in the field of epilepsy, known particularly for his work
in clinical neurophysiology, epilepsy surgery, and investigational
therapeutics. He has
published approximately 500 peer-reviewed papers, reviews, and book chapters,
and several books. He is presently Editor-in-Chief of Epilepsia and is a
former president of the American Clinical Neurophysiology Society and the
Philadelphia Neurological Society. He received the J. Kiffin Penry award from
the American Epilepsy Society in 2018 and the Ambassador for Epilepsy award
from the International League Against Epilepsy in 2021.
|
Session:
Selecting Medications for Epilepsy, Therapeutic Drug Monitoring and Drug Taper Course Description: This educational presentation will use lecture and various case examples to illustrate that most epileptic seizures are worth treating. This discussion will review risk factors throughout the illness, the elements of pharmacotherapy and expected responses to medication. Issues with adherence to therapy and relapse risk after medication is discussed. Learning Objectives:
|
To receive a Continuing Medical Education certificate, take the pre-test, attend the presentation,
complete the post-test, and the post-presentation evaluation.
